Uncategorized
Neurotech Pharmaceuticals Appoints Thomas Aaberg Jr., M.D. as Chief Medical Officer
CUMBERLAND, R.I.--(BUSINESS WIRE)--Neurotech Pharmaceuticals, a biotechnology company developing transformational, sight-saving therapeutics for the treatment of chronic eye diseases, announced today that Thomas Aaberg, Jr., M.D. has been appointed to the position of Chief Medical Officer (CMO). Dr. Aaberg’s responsibilities will include the execution of clinical studies, patient safety, and the management of Medical Affairs; supporting the required regulatory submissions; and supporting the Co